These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 32541897)

  • 1. Targeted protein degradation as a powerful research tool in basic biology and drug target discovery.
    Wu T; Yoon H; Xiong Y; Dixon-Clarke SE; Nowak RP; Fischer ES
    Nat Struct Mol Biol; 2020 Jul; 27(7):605-614. PubMed ID: 32541897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted protein degradation and the enzymology of degraders.
    Fisher SL; Phillips AJ
    Curr Opin Chem Biol; 2018 Jun; 44():47-55. PubMed ID: 29885948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Protein Degradation: from Chemical Biology to Drug Discovery.
    Cromm PM; Crews CM
    Cell Chem Biol; 2017 Sep; 24(9):1181-1190. PubMed ID: 28648379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on the development of first-in-class protein degraders.
    Rambacher KM; Calabrese MF; Yamaguchi M
    Future Med Chem; 2021 Jul; 13(14):1203-1226. PubMed ID: 34015962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule Degraders beyond PROTACs-Challenges and Opportunities.
    Kastl JM; Davies G; Godsman E; Holdgate GA
    SLAS Discov; 2021 Apr; 26(4):524-533. PubMed ID: 33632029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monomeric Targeted Protein Degraders.
    Hanan EJ; Liang J; Wang X; Blake RA; Blaquiere N; Staben ST
    J Med Chem; 2020 Oct; 63(20):11330-11361. PubMed ID: 32352776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Quantitative Assay Technologies for Accelerating the Discovery and Optimization of Targeted Protein Degradation Therapeutics.
    Simard JR; Lee L; Vieux E; Improgo R; Tieu T; Phillips AJ; Fisher SL; Pollock RM; Park E
    SLAS Discov; 2021 Apr; 26(4):503-517. PubMed ID: 33430712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein degradation for drug discovery.
    Ciulli A; Farnaby W
    Drug Discov Today Technol; 2019 Apr; 31():1-3. PubMed ID: 31200853
    [No Abstract]   [Full Text] [Related]  

  • 9. Protein degradation technology: a strategic paradigm shift in drug discovery.
    Li H; Dong J; Cai M; Xu Z; Cheng XD; Qin JJ
    J Hematol Oncol; 2021 Sep; 14(1):138. PubMed ID: 34488823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PROTACs: New method to degrade transcription regulating proteins.
    Hu B; Zhou Y; Sun D; Yang Y; Liu Y; Li X; Li H; Chen L
    Eur J Med Chem; 2020 Dec; 207():112698. PubMed ID: 32858471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted protein knockdown using small molecule degraders.
    Raina K; Crews CM
    Curr Opin Chem Biol; 2017 Aug; 39():46-53. PubMed ID: 28605671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs.
    An S; Fu L
    EBioMedicine; 2018 Oct; 36():553-562. PubMed ID: 30224312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical control of targeted protein degradation.
    Reynders M; Trauner D
    Cell Chem Biol; 2021 Jul; 28(7):969-986. PubMed ID: 34115971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locus-Specific Knock-In of a Degradable Tag for Target Validation Studies.
    Brand M; Winter GE
    Methods Mol Biol; 2019; 1953():105-119. PubMed ID: 30912018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homo-PROTACs for the Chemical Knockdown of Cereblon.
    Steinebach C; Lindner S; Udeshi ND; Mani DC; Kehm H; Köpff S; Carr SA; Gütschow M; Krönke J
    ACS Chem Biol; 2018 Sep; 13(9):2771-2782. PubMed ID: 30118587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action.
    Riching KM; Mahan S; Corona CR; McDougall M; Vasta JD; Robers MB; Urh M; Daniels DL
    ACS Chem Biol; 2018 Sep; 13(9):2758-2770. PubMed ID: 30137962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches for small molecule-induced protein degradation.
    Wu S; Xiao H; Sun Q
    Future Med Chem; 2021 Mar; 13(5):439-441. PubMed ID: 33438469
    [No Abstract]   [Full Text] [Related]  

  • 18. Bifunctional Molecules beyond PROTACs.
    Conway SJ
    J Med Chem; 2020 Mar; 63(6):2802-2806. PubMed ID: 32157887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phenotypic Approach for the Identification of New Molecules for Targeted Protein Degradation Applications.
    Stacey P; Lithgow H; Lewell X; Konopacka A; Besley S; Green G; Whatling R; Law R; Röth S; Sapkota GP; Smith IED; Burley GA; Harling J; Benowitz AB; Queisser MA; Muelbaier M
    SLAS Discov; 2021 Aug; 26(7):885-895. PubMed ID: 34041938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Vital Role of Proteomics in Characterizing Novel Protein Degraders.
    Zhang AX; Cassidy K; Dahl G; Moreau K; Pachl F; Zuhl AM
    SLAS Discov; 2021 Apr; 26(4):518-523. PubMed ID: 33615886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.